These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 9034592
1. Antisense approaches to the gene therapy of cancer--'Recnac'. Gibson I. Cancer Metastasis Rev; 1996 Sep; 15(3):287-99. PubMed ID: 9034592 [Abstract] [Full Text] [Related]
2. Therapeutic antisense and ribozymes. Rossi JJ. Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [Abstract] [Full Text] [Related]
4. Specific regulation of gene expression by antisense nucleic acids: a summary of methodologies and associated problems. Kawasaki H, Machida M, Komatsu M, Li HO, Murata T, Tsutsui H, Fujita A, Matsumura M, Kobayashi Y, Taira K, Yokoyama KK. Artif Organs; 1996 Aug; 20(8):836-48. PubMed ID: 8853793 [Abstract] [Full Text] [Related]
5. Antisense oligonucleotides as therapeutic agents. Alama A, Barbieri F, Cagnoli M, Schettini G. Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660 [Abstract] [Full Text] [Related]
6. A good antisense molecule is hard to find. Branch AD. Trends Biochem Sci; 1998 Feb; 23(2):45-50. PubMed ID: 9538686 [Abstract] [Full Text] [Related]
7. Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics. Zhou T, Kim Y, MacLeod AR. Methods Mol Biol; 2016 Feb; 1402():199-213. PubMed ID: 26721493 [Abstract] [Full Text] [Related]
13. Design and applications of modified oligonucleotides. Gallo M, Montserrat JM, Iribarren AM. Braz J Med Biol Res; 2003 Feb; 36(2):143-51. PubMed ID: 12563516 [Abstract] [Full Text] [Related]
14. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty. Pickering JG, Isner JM, Ford CM, Weir L, Lazarovits A, Rocnik EF, Chow LH. Circulation; 1996 Feb 15; 93(4):772-80. PubMed ID: 8641007 [Abstract] [Full Text] [Related]
15. Antisense oligonucleotide therapy in the management of bladder cancer. So A, Rocchi P, Gleave M. Curr Opin Urol; 2005 Sep 15; 15(5):320-7. PubMed ID: 16093856 [Abstract] [Full Text] [Related]
16. Antisense approaches to cancer gene therapy. Mercola D, Cohen JS. Cancer Gene Ther; 1995 Mar 15; 2(1):47-59. PubMed ID: 7621254 [Abstract] [Full Text] [Related]
17. RNA as a target for developing antivirals. McKnight KL, Heinz BA. Antivir Chem Chemother; 2003 Mar 15; 14(2):61-73. PubMed ID: 12856917 [Abstract] [Full Text] [Related]
18. Therapeutic applications of antisense oligonucleotides in asthma and allergy. Isidoro-García M, Dávila I. Recent Pat Inflamm Allergy Drug Discov; 2007 Nov 15; 1(3):171-5. PubMed ID: 19075979 [Abstract] [Full Text] [Related]
19. [The application of antisense technology in ophthalmology]. Guo Y, Ge J. Yan Ke Xue Bao; 1998 Jun 15; 14(2):108-15. PubMed ID: 12580046 [Abstract] [Full Text] [Related]
20. [Antisense nucleic acids and gene therapy]. Saison-Behmoaras E. Bull Cancer; 1995 Mar 15; 82(3):224-5. PubMed ID: 7655155 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]